HKG Equity Snapshot

1093 Weekly Equity Report

CSPC Pharmaceutical Group Limited

Interactive chart JSON snapshot
Latest Close 7.24 HKD 12 Jun 2026
1W Return 0.0% latest completed week
4W Return -6.9% short-term follow-through
12W Return -17.7% quarterly tape
Trend Breadth 51.9% 27 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
Company Brief

What the company does

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent infection induced by chemotherapy; and Keaili …

Snapshot

What the weekly tape is saying

1093 closed the latest completed week at 7.24 HKD. The 4-week return is -6.9% and the 12-week return is -17.7%. Trend Signal is inactive, Market Dynamics is -1.22. Setup signature: Risk-first tape with a 21/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -17.0%
Volume 1.1x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 29 Persistence of active Trend Signal over the last year and current streak.
Momentum 18 Blend of 4-week and 12-week follow-through.
Dynamics 26 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 5 Relative leadership and short-term RS change.
Volume 45 Participation compared with the 13-week volume baseline.
Risk Control 5 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
8.72 HKD
Vs Trend Line
-17.0%
Fair Value
6.69 HKD
Vs Fair Value
8.2%
52W High
11.45 HKD
52W Low
6.64 HKD
Drawdown
-36.8%
Range Position
12.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W -6.9%
12W -17.7%
26W -5.5%
52W -16.8%

Trend read

Active Streak
0 weeks
52W Active Weeks
27
52W Active Breadth
51.9%
Sector Scope
HK Healthcare
Sector Rank
90 of 257
Sector Percentile
65.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.22
4W MD Change
-24.0%
Relative Strength
-14.82
4W RS Change
-8.7%
Expectation
Undecided
Probability
45.38%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
477.0M
13W Average
440.7M
52W Average
620.3M
Vs 13W
1.1x
Vs 52W
0.8x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.5%
52W Volatility
6.3%
Upside Weeks
21
Downside Weeks
30
Downside Breadth
57.7%
Avg Gain / Loss
6.3% / -4.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
HKD
Market Cap
86.5B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 7.24 HKD 0.0% 8.72 HKD 6.69 HKD -1.22 -14.82 477.0M Off
5 Jun 2026 7.24 HKD -3.5% 8.75 HKD 6.68 HKD -1.13 -15.98 583.2M Off
29 May 2026 7.50 HKD -2.5% 8.75 HKD 6.68 HKD -1.09 -14.10 722.2M Off
22 May 2026 7.69 HKD -1.2% 8.76 HKD 6.67 HKD -1.09 -13.57 372.1M Off
15 May 2026 7.78 HKD -5.1% 8.76 HKD 6.66 HKD -0.99 -13.63 425.4M Off
8 May 2026 8.20 HKD -2.5% 8.80 HKD 6.65 HKD -0.92 -10.18 297.7M Off
1 May 2026 8.41 HKD -6.3% 8.84 HKD 6.64 HKD -0.80 -5.32 343.3M On
24 Apr 2026 8.98 HKD 0.2% 8.87 HKD 6.64 HKD -0.58 0.63 385.9M On
17 Apr 2026 8.96 HKD -3.2% 8.87 HKD 6.62 HKD -0.35 0.13 372.1M On
10 Apr 2026 9.26 HKD -4.6% 8.90 HKD 6.61 HKD -0.24 5.08 210.6M On
3 Apr 2026 9.71 HKD 4.5% 8.93 HKD 6.60 HKD -0.13 14.33 427.1M On
27 Mar 2026 9.29 HKD 5.6% 8.98 HKD 6.58 HKD -0.03 11.06 748.5M On
20 Mar 2026 8.80 HKD 2.4% 9.00 HKD 6.57 HKD 0.09 4.82 364.2M On
13 Mar 2026 8.59 HKD -8.3% 9.05 HKD 6.55 HKD 0.32 2.45 486.4M Off